Kasey Vold

Kasey Vold currently serves as the Clinical QA Manager at ALX Oncology since January 2023. Previously, Kasey held positions at Ultragenyx Pharmaceutical Inc., starting as a Quality Compliance Summer Intern in 2017, where support was provided for Phase III clinical trial submissions, resulting in successful regulatory approvals. Following this role, Kasey advanced to become an Analyst in Clinical QA and GxP Compliance, executing GCP audits of clinical vendors and sites while representing GCP Compliance for clinical study teams. Kasey's expertise in GxP Compliance was further demonstrated as a GxP Compliance Specialist, providing training for study teams in preparation for global regulatory inspections. Kasey holds a degree in Political Science from the University of Illinois Urbana-Champaign, earned in 2018.